4.8 Article

Evidence for evolutionary divergence of activity-dependent gene expression in developing neurons

Journal

ELIFE
Volume 5, Issue -, Pages -

Publisher

ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.20337

Keywords

-

Categories

Funding

  1. Biotechnology and Biological Sciences Research Council
  2. Royal Society
  3. Medical Research Council
  4. Wellcome Trust
  5. Wellcome Trust [098327/Z/12/Z] Funding Source: Wellcome Trust
  6. MRC [G0601056, G0902044, MR/K014137/1] Funding Source: UKRI
  7. Medical Research Council [MR/K014137/1, G0902044, G0601056, 1482029] Funding Source: researchfish
  8. The Francis Crick Institute [10194, 10197] Funding Source: researchfish
  9. Wellcome Trust [098327/Z/12/Z] Funding Source: researchfish

Ask authors/readers for more resources

Evolutionary differences in gene regulation between humans and lower mammalian experimental systems are incompletely understood, a potential translational obstacle that is challenging to surmount in neurons, where primary tissue availability is poor. Rodent-based studies show that activity-dependent transcriptional programs mediate myriad functions in neuronal development, but the extent of their conservation in human neurons is unknown. We compared activity-dependent transcriptional responses in developing human stem cell-derived cortical neurons with those induced in developing primary-or stem cell-derived mouse cortical neurons. While activity-dependent gene-responsiveness showed little dependence on developmental stage or origin (primary tissue vs. stem cell), notable species-dependent differences were observed. Moreover, differential species-specific gene ortholog regulation was recapitulated in aneuploid mouse neurons carrying human chromosome-21, implicating promoter/enhancer sequence divergence as a factor, including human-specific activity-responsive AP-1 sites. These findings support the use of human neuronal systems for probing transcriptional responses to physiological stimuli or indeed pharmaceutical agents.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Neurosciences

Identifying foetal forebrain interneurons as a target for monogenic autism risk factors and the polygenic 16p11.2 microdeletion

Yifei Yang, Sam A. Booker, James M. Clegg, Idoia Quintana-Urzainqui, Anna Sumera, Zrinko Kozic, Owen Dando, Sandra Martin Lorenzo, Yann Herault, Peter C. Kind, David J. Price, Thomas Pratt

Summary: This study combines bioinformatics analysis of human foetal cerebral cortex gene expression data with anatomical and electrophysiological analysis of a 16p11.2(+/-) rat model to investigate the impact of genetic risk factors on the development of inhibitory neurons. The study identifies a subset of human interneurons vulnerable to mutations causing autism and reports interneuron phenotypes in post-natal 16p11.2(+/-) rats.

BMC NEUROSCIENCE (2023)

Review Biochemistry & Molecular Biology

Long-term plasticity of astrocytic phenotypes and their control by neurons in health and disease

Kyle S. Wardlaw, Giles E. Hardingham

Summary: The brain is a complex organ with various types of cells. Each cell type's functions are influenced by each other, and neurons control the properties of astrocytes to alter their homeostatic capacity. Astrocytes play a critical role in sustaining functional neuronal circuits and their functions can be regulated by signals from neurons. Understanding these signals could potentially be used to promote astrocyte-mediated neurosupport in brain disorders.

ESSAYS IN BIOCHEMISTRY (2023)

Review Endocrinology & Metabolism

Blood-CNS barrier dysfunction in amyotrophic lateral sclerosis: Proposed mechanisms and clinical implications

Moritz Steinruecke, Rebecca Murphy Lonergan, Bhuvaneish T. Selvaraj, Siddharthan Chandran, Blanca Diaz-Castro, Maria Stavrou

Summary: There is strong evidence suggesting blood-brain and blood-spinal cord barrier dysfunction in early stages of neurodegenerative diseases, such as ALS. In ALS, mitochondrial dysfunction, astrocyte pathology, and neuroinflammation are believed to contribute to impairment of the blood-central nervous system barrier (BCNSB). Mitochondrial dysfunction leads to motor neuron death, astrocytes play key roles at the barrier and exhibit inflammatory markers, and factors like TDP-43 pathology and systemic inflammation affect BCNSB integrity. Understanding BCNSB dysfunction in ALS has translational implications for biomarker development, restoration approaches, and in vitro modeling of the neurogliovascular system.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2023)

Review Medicine, General & Internal

Systematic, comprehensive, evidence-based approach to identify neuroprotective interventions for motor neuron disease: using systematic reviews to inform expert consensus

Charis Wong, Jenna M. Gregory, Jing Liao, Kieren Egan, Hanna M. Vesterinen, Aimal Ahmad Khan, Maarij Anwar, Caitlin Beagan, Fraser S. Brown, John Cafferkey, Alessandra Cardinali, Jane Yi Chiam, Claire Chiang, Victoria Collins, Joyce Dormido, Elizabeth Elliott, Peter Foley, Yu Cheng Foo, Lily Fulton-Humble, Angus B. Gane, Stella A. Glasmacher, Aine Heffernan, Kiran Jayaprakash, Nimesh Jayasuriya, Amina Kaddouri, Jamie Kiernan, Gavin Langlands, D. Leighton, Jiaming Liu, James Lyon, Arpan R. Mehta, Alyssa Meng, Vivienne Nguyen, Na Hyun Park, Suzanne Quigley, Yousuf Rashid, Andrea Salzinger, Bethany Shiell, Ankur Singh, Tim Soane, Alexandra Thompson, Olaf Tomala, Fergal M. Waldron, Bhuvaneish T. Selvaraj, Jeremy Chataway, Robert Swingler, Peter Connick, Suvankar Pal, Siddharthan Chandran, Malcolm Macleod

Summary: This study presents a systematic and structured evidence-based approach to select the first two drugs for evaluation in the MND-SMART trial. Through a comprehensive evaluation of clinical studies and animal models, memantine and trazodone were selected as the first two drugs based on supportive evidence.

BMJ OPEN (2023)

Article Developmental Biology

Craniofacial dysmorphology in Down syndrome is caused by increased dosage of Dyrk1a and at least three other genes

Yushi Redhead, Dorota Gibbins, Eva Lana-Elola, Sheona Watson-Scales, Lisa Dobson, Matthias Krause, Karen J. Liu, Elizabeth M. C. Fisher, Jeremy B. A. Green, Victor L. J. Tybulewicz

Summary: Down syndrome (DS) is a common human chromosomal abnormality that leads to various phenotypic features, including craniofacial dysmorphology. Through analysis of a DS mouse model and genetic mapping, it was found that four regions on mouse chromosome 16, which correspond to Hsa21 in humans, contain dosage-sensitive genes that contribute to DS craniofacial abnormalities, with Dyrk1a identified as one of the causative genes. The study revealed that the earliest and most severe defects in the DS mouse skulls occur in bones of neural crest origin, and that abnormal mineralization of the skull base synchondroses is present. Additionally, increased dosage of Dyrk1a was found to result in decreased proliferation of neural crest cells and a reduction in size and cellularity of the frontal bone primordia.

DEVELOPMENT (2023)

Article Cell Biology

Genetic dissection of triplicated chromosome 21 orthologs yields varying skeletal traits in Down syndrome model mice

Kourtney Sloan, Jared Thomas, Matthew Blackwell, Deanna Voisard, Eva Lana-Elola, Sheona Watson-Scales, Daniel L. Roper, Joseph M. Wallace, Elizabeth M. C. Fisher, Victor L. J. Tybulewicz, Randall J. Roper

Summary: This study investigates the effects of triplicated genes on mouse skeletal phenotypes and finds that they can both improve and worsen bone deficits.

DISEASE MODELS & MECHANISMS (2023)

Review Chemistry, Medicinal

Molecular mechanisms of amyotrophic lateral sclerosis as broad therapeutic targets for gene therapy applications utilizing adeno-associated viral vectors

Jessica Merjane, Roger Chung, Rickie Patani, Leszek Lisowski

Summary: Despite the mysterious etiology, differentiated treatments are required for ALS to address both familial and sporadic cases. Targeting mechanisms of defective protein homeostasis and RNA processing, as well as exploring the use of gene therapy through adeno-associated virus (AAV) for gene delivery to the CNS, might provide potential therapeutic interventions. Overall, there is a strong need for disease modifying treatments for ALS that can effectively treat the full spectrum of cases.

MEDICINAL RESEARCH REVIEWS (2023)

Review Clinical Neurology

Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration

Rickie Patani, Giles E. Hardingham, Shane A. Liddelow

Summary: Therapies that prevent neuronal loss in neuroinflammation and neurodegenerative disease are still elusive. This review highlights the importance of 'omics' technologies in characterizing the functional states of reactive astrocytes in different pathological scenarios.

NATURE REVIEWS NEUROLOGY (2023)

Article Multidisciplinary Sciences

Astrocyte-oligodendrocyte interaction regulates central nervous system regeneration

Irene Molina-Gonzalez, Rebecca K. Holloway, Zoeb Jiwaji, Owen Dando, Sarah A. Kent, Katie Emelianova, Amy F. Lloyd, Lindsey H. Forbes, Ayisha Mahmood, Thomas Skripuletz, Viktoria Gudi, James A. Febery, Jeffrey A. Johnson, Jill H. Fowler, Tanja Kuhlmann, Anna Williams, Siddharthan Chandran, Martin Stangel, Andrew J. M. Howden, Giles E. Hardingham, Veronique E. Miron

Summary: Failed regeneration of myelin around neuronal axons following central nervous system damage contributes to nerve dysfunction and clinical decline in various neurological conditions. This study shows that the interaction between astrocytes and mature myelin-forming oligodendrocytes is crucial for remyelination. Astrocytes support the survival of regenerating oligodendrocytes by downregulating the Nrf2 pathway and activating the cholesterol biosynthesis pathway. This discovery reveals a drug strategy for central nervous system regeneration by targeting the astrocyte-oligodendrocyte interaction.

NATURE COMMUNICATIONS (2023)

Article Cell Biology

Astrocytes mediate cell non-autonomous correction of aberrant firing in human FXS neurons

Shreya Das Sharma, Bharath Kumar Reddy, Rakhi Pal, Tuula E. Ritakari, James D. Cooper, Bhuvaneish T. Selvaraj, Peter C. Kind, Siddharthan Chandran, David J. A. Wyllie, Sumantra Chattarji

Summary: Previous pre-clinical studies on fragile X syndrome (FXS) have mainly focused on neurons and the role of glia has been largely unexplored. This study investigates the astrocytic regulation of aberrant firing in FXS neurons derived from human pluripotent stem cells. It was found that co-culturing FXS cortical neurons with FXS astrocytes led to frequent short-duration bursts of action potentials, while co-culturing control neurons with control astrocytes resulted in less frequent, longer-duration bursts. The astrocyte genotype was found to determine the firing phenotype of the neurons, and the astroglial-derived protein, S100b, played a role in restoring normal firing.

CELL REPORTS (2023)

Article Cell Biology

A 3D cell culture system for bioengineering human neuromuscular junctions to model ALS

Bita Massih, Alexander Veh, Maren Schenke, Simon Mungwa, Bettina Seeger, Bhuvaneish T. Selvaraj, Siddharthan Chandran, Peter Reinhardt, Jared Sterneckert, Andreas Hermann, Michael Sendtner, Patrick Lueningschroer

Summary: This article introduces a human neuromuscular co-culture system that enables the formation of neuromuscular junctions by differentiating induced pluripotent stem cells into motor neurons and 3D skeletal muscle tissue. The system is suitable for modeling the pathophysiology of motor neuron diseases and has been used to study the synaptic coupling and muscle contraction in Amyotrophic Lateral Sclerosis (ALS). This in vitro model recapitulates aspects of human physiology and is of great importance for studying human motor neurons in health and disease.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2023)

Article Clinical Neurology

Elevated 4R tau contributes to endolysosomal dysfunction and neurodegeneration in VCP-related frontotemporal dementia

Christy Hung, Rickie Patani

Summary: This study uses a patient-derived stem cell model to uncover disease mechanisms in a type of dementia closely related to motor neuron disease called FTD. Specifically, they show that the increase of a particular type of tau protein-called the 4R isoform-drives degeneration of nerve cells, thereby causing the disease.

BRAIN (2023)

Article Plant Sciences

A phospho-dawn of protein modification anticipates light onset in the picoeukaryote Ostreococcus tauri

Zeenat B. Noordally, Matthew M. Hindle, Sarah F. Martin, Daniel D. Seaton, T. Ian Simpson, Thierry Le Bihan, Andrew J. Millar

Summary: This study compared transcriptome data with partial proteome and phosphoproteome data from the alga Ostreococcus tauri. They found that 10% of quantified proteins and two-thirds of phosphorylated proteins showed rhythmic changes. Mathematical modeling indicated that light-stimulated protein synthesis could explain the clustering of protein peaks during the daytime. The study also observed anticipatory phosphorylation before dawn, suggesting clock-regulated phosphodawn prepares the cells for daytime functions.

JOURNAL OF EXPERIMENTAL BOTANY (2023)

Article Neurosciences

Nucleocytoplasmic mRNA redistribution accompanies RNA binding protein mislocalization in ALS motor neurons and is restored by VCP ATPase inhibition

Oliver J. Ziff, Jasmine Harley, Yiran Wang, Jacob Neeves, Giulia Tyzack, Fairouz Ibrahim, Mark Skehel, Anob M. Chakrabarti, Gavin Kelly, Rickie Patani

Summary: This study investigates the mislocalization of mRNA and protein in ALS patients. The findings suggest a link between RBP mislocalization and mRNA redistribution in ALS motor neurons. Treatment with the VCP ATPase inhibitor ML240 partially restores mRNA and protein localization and reduces oxidative stress and DNA damage.

NEURON (2023)

Article Biochemistry & Molecular Biology

Direct m6A recognition by IMP1 underlays an alternative model of target selection for non-canonical methyl-readers

Giuseppe Nicastro, Giancarlo Abis, Pierre Klein, Sofia Esteban-Serna, Christopher Gallagher, Belen Chaves-Arquero, Yuyang Cai, Angelo Miguel Figueiredo, Stephen R. Martin, Rickie Patani, Ian A. Taylor, Andres Ramos

Summary: m6A methylation is an important regulatory layer in organismal development and is associated with various cancers and neuro-pathologies. RNA binding proteins, known as m6A readers, integrate the information encoded by m6A methylation into existing RNA regulatory networks. This study reveals that the reader IMP1 recognizes m6A through a specific hydrophobic platform, forming a stable and high-affinity interaction. The recognition is conserved across evolution and independent of the sequence context, but builds upon the strong sequence specificity of IMP1 for GGAC RNA. These findings propose a context-dependent role for methylation in the recognition of IMP1 targets, dependent on the cellular concentration of IMP1, as opposed to the YTH proteins.

NUCLEIC ACIDS RESEARCH (2023)

No Data Available